Abstract:Cleavage of proteins in the extracellular milieu, including hormones, growth factors and their receptors, ion channels, and various cell adhesion and extracellular matrix molecules, plays a key role in the regulation of cell behavior. Among more than 500 proteolytic enzymes encoded by mammalian genomes, membrane-anchored serine proteases (MASPs), which are expressed on the surface of epithelial cells of all major organs, are excellently suited to mediate signal transduction across the epithelia and are increas… Show more
“…As part of this family, there is a subgroup composed of membrane-anchored serine proteases, which is divided into (i) GPI-serine proteases that are anchored in the plasma membrane by a glycosylphosphatidylinositol anchor, (ii) Type I-serine proteases that have a single pass domain in the plasma membrane located close to the C-terminus end, and (iii) Type II-serine proteases that are anchored in the plasma membrane and have an anchor sign located close to the N-terminus end [77,82].…”
Section: Proteases and Hpv Carcinogenesismentioning
confidence: 99%
“…Different studies have shown that when matriptase is less expressed, there is also less activation of uPA in the cells of ovary and prostate cancer [87,88]. Matriptase is also responsible for activating the PI3K-Akt-mTOR pathway after the proteolytic activation of the hepatocyte growth factor precursor (pro-HGF), which can promote cell proliferation and decrease apoptosis [82]. PAR-2 (protease-activated receptor 2), a receptor expressed in different cell types, is related to cell adhesion, the maintenance of the skin barrier, and inflammatory responses [89,90].…”
Section: Proteases and Hpv Carcinogenesismentioning
Persistent infection with Human papillomavirus (HPV) is the main etiologic factor for pre-malignant and malignant cervical lesions. Moreover, HPV is also associated with oropharynx and other anogenital carcinomas. Cancer-causing HPV viruses classified as group 1 carcinogens include 12 HPV types, with HPV 16 and 18 being the most prevalent. High-risk HPVs express two oncoproteins, E6 and E7, the products of which are responsible for the inhibition of p53 and pRB proteins, respectively, in human keratinocytes and cellular immortalization. p53 and pRB are pleiotropic proteins that regulate the activity of several signaling pathways and gene expression. Among the important factors that are augmented in HPV-mediated carcinogenesis, proteases not only control processes involved in cellular carcinogenesis but also control the microenvironment. For instance, genetic polymorphisms of matrix metalloproteinase 1 (MMP-1) are associated with carcinoma invasiveness. Similarly, the serine protease inhibitors hepatocyte growth factor activator inhibitor-1 (HAI-1) and -2 (HAI-2) have been identified as prognostic markers for HPV-dependent cervical carcinomas. This review highlights the most crucial mechanisms involved in HPV-dependent carcinogenesis, and includes a section on the proteolytic cascades that are important for the progression of this disease and their impact on patient health, treatment, and survival.
“…As part of this family, there is a subgroup composed of membrane-anchored serine proteases, which is divided into (i) GPI-serine proteases that are anchored in the plasma membrane by a glycosylphosphatidylinositol anchor, (ii) Type I-serine proteases that have a single pass domain in the plasma membrane located close to the C-terminus end, and (iii) Type II-serine proteases that are anchored in the plasma membrane and have an anchor sign located close to the N-terminus end [77,82].…”
Section: Proteases and Hpv Carcinogenesismentioning
confidence: 99%
“…Different studies have shown that when matriptase is less expressed, there is also less activation of uPA in the cells of ovary and prostate cancer [87,88]. Matriptase is also responsible for activating the PI3K-Akt-mTOR pathway after the proteolytic activation of the hepatocyte growth factor precursor (pro-HGF), which can promote cell proliferation and decrease apoptosis [82]. PAR-2 (protease-activated receptor 2), a receptor expressed in different cell types, is related to cell adhesion, the maintenance of the skin barrier, and inflammatory responses [89,90].…”
Section: Proteases and Hpv Carcinogenesismentioning
Persistent infection with Human papillomavirus (HPV) is the main etiologic factor for pre-malignant and malignant cervical lesions. Moreover, HPV is also associated with oropharynx and other anogenital carcinomas. Cancer-causing HPV viruses classified as group 1 carcinogens include 12 HPV types, with HPV 16 and 18 being the most prevalent. High-risk HPVs express two oncoproteins, E6 and E7, the products of which are responsible for the inhibition of p53 and pRB proteins, respectively, in human keratinocytes and cellular immortalization. p53 and pRB are pleiotropic proteins that regulate the activity of several signaling pathways and gene expression. Among the important factors that are augmented in HPV-mediated carcinogenesis, proteases not only control processes involved in cellular carcinogenesis but also control the microenvironment. For instance, genetic polymorphisms of matrix metalloproteinase 1 (MMP-1) are associated with carcinoma invasiveness. Similarly, the serine protease inhibitors hepatocyte growth factor activator inhibitor-1 (HAI-1) and -2 (HAI-2) have been identified as prognostic markers for HPV-dependent cervical carcinomas. This review highlights the most crucial mechanisms involved in HPV-dependent carcinogenesis, and includes a section on the proteolytic cascades that are important for the progression of this disease and their impact on patient health, treatment, and survival.
“…Importantly, in expression systems ENaC can be fully activated by coexpressing membraneanchored serine proteases (43)(44)(45)(46). The family of membrane-anchored serine proteases consists of 20 members identified in human to date (47)(48)(49). They share a conserved extracellular catalytic domain and J o u r n a l P r e -p r o o f 4 are anchored directly to the plasma membrane via a GPI-anchor or a transmembrane domain.…”
“…Depending on the similarity in modular arrangements in the stem region, TTSPs can be divided into four subgroups, that is, hepsin (also known as TMPRSS1), matriptase, HAT, and corin subgroups [12,13]. Members of the TTSP family are expressed in many tissues, where they participate in diverse processes, including food digestion [14], epithelial differentiation [15,16], intestinal barrier function [17][18][19], skin permeability [20][21][22], sodium homeostasis [23,24], iron metabolism [25], and vascular remodeling [26,27]. TTSP deficiencies or overexpression has been reported in patients with malnutrition [14], skin defects [28,29], intestinal disease [30], iron deficiency anemia [25], hypertension [31,32], kidney disease [33], and cancer [34].…”
Cell membrane-bound serine proteases are important in the maintenance of physiological homeostasis. Hepsin is a type II transmembrane serine protease highly expressed in the liver. Recent studies indicate that hepsin activates prohepatocyte growth factor in the liver to enhance Met signaling, thereby regulating glucose, lipid, and protein metabolism. In addition, hepsin functions in nonhepatic tissues, including the adipose tissue, kidney, and inner ear, to regulate adipocyte differentiation, urinary protein processing, and auditory function, respectively. In mouse models, hepsin deficiency lowers blood glucose, lipid, and protein levels, impairs uromodulin assembly in renal epithelial cells, and causes hearing loss. Elevated hepsin expression has also been found in many cancers. As a type II transmembrane protease, cell surface expression and zymogen activation are essential for hepsin activity. In this review, we discuss the current knowledge regarding hepsin biosynthesis, activation, and functions in pathobiology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.